By Justin Petrone

Baylor College of Medicine's Human Genome Sequencing Center has standardized its target-enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology, Roche said this week.

Baylor plans to sequence more than 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases. The center will use NimbleGen's SeqCap EZ Exome and customized NimbleGen exome designs as its exome-capture technology of choice, according the firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.